產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-ATP6V0A2抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢(xún)訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-ATP6V0A2抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-ATP6V0A2
Cat. Number:
Anti-ATP6V0A2抗體KL-12761R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
The protein encodedAnti-ATP6V0A2抗體 by this gene is a subunit of the vacuolar ATPase (v-ATPase), an heteromultimeric enzyme that is present in intracellular vesicles and in the plasma membrane of specialized cells, and which is essential for the acidification of diverse cellular components. V-ATPase is comprised of a membrane peripheral V(1) domain for ATP hydrolysis, and an integral membrane V(0) domain for proton translocation. The subunit encoded by this gene is a component of the V(0) domain. Mutations in this gene are a cause of both cutis laxa type II and wrinkly skin syndrome. [provided by RefSeq, Jul 2009]
Also known as:
a2; A2V ATPase; ARCL; ATP6a2; ATP6N1D; ATP6V0A2; ATPase, H+ transporting, lysosomal V0 subunit a isoform Anti-ATP6V0A2抗體2; ATPase, H+ transporting, lysosomal V0 subunit a2; Infantile malignant osteopetrosis; J6B7; Lysosomal H(+) transporting ATPase V0 subunit a2; Lysosomal H(+)-transporting ATPase V0 subunit a2; regeneration and tolerance factor; Stv1; TJ6; TJ6M; TJ6s; V ATPase 116 kDa isoform a2; V type proton ATPase 116 kDa subunit a; V type proton ATPase 116 kDa subunit a isoform 2; V-ATPase 116 kDa isoform a2; V-type proton ATPase 116 kDa subunit a isoform 2; Vacuolar proton translocating ATPase 116 kDa subunit a; Vacuolar proton translocating ATPase 116 kDa subunit a isoform 2; Vph1; VPP2_HUMAN; WSS.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
●
Immunogen: KLH conjugated synthetic peptide derived from human ATP6V0A2.
●
Predicted Molecular Weight: 98kDa.
Storage:
Shipped Anti-ATP6V0A2抗體at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions Anti-ATP6V0A2抗體must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions Anti-ATP6V0A2抗體must be determined by the end user.
kl750Si01 腫瘤壞死因子配體超家族成員13(TNFSF13)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Ligand Superfamily, Member 13 (TNFSF13)
kl065Mu01 丙氨酸氨肽酶(AAP)多克隆抗體 Polyclonal Antibody to Alanine Aminopeptidase (AAP)
kl429Mu01 凋亡關(guān)聯(lián)酪氨酸激酶(AATK)多克隆抗體 Polyclonal Antibody to Apoptosis Associated Tyrosine Kinase (AATK)
kl018Mu01 α-乳清蛋白(αLA)多克隆抗體 Polyclonal Antibody to Alpha-Lactalbumin (aLA)
kl220Mu01 博來(lái)霉素水解酶(BLMH)多克隆抗體 Polyclonal Antibody to Bleomycin Hydrolase (BLMH)
kl620Mu01 C4結(jié)合蛋白α(C4BPα)多克隆抗體 Polyclonal Antibody to C4 Binding Protein Alpha (C4BPa)
kl172Mu01 CD1d分子(CD1d)多克隆抗體 Polyclonal Antibody to Cluster Of Differentiation 1d (CD1d)
kl837Mu01 白介素2受體α(IL2Rα)多克隆抗體 Polyclonal Antibody to Interleukin 2 Receptor Alpha (IL2Ra)
kl874Mu02 凝血因子Ⅶ(F7)多克隆抗體 Polyclonal Antibody to Coagulation Factor VII (F7)
kl678Mu01 FK506結(jié)合蛋白8(FKBP8)多克隆抗體 Polyclonal Antibody to FK506 Binding Protein 8 (FKBP8)
kl764Mu01 叉頭框蛋白O1(FOXO1)多克隆抗體 Polyclonal Antibody to Forkhead Box Protein O1 (FOXO1)
kl195Hu01 膠質(zhì)細(xì)胞成熟因子γ(MPFγ)多克隆抗體 Polyclonal Antibody to Glia Maturation Factor Gamma (GMFg)
kl300Mu01 糖蛋白Ⅴ(GP5)多克隆抗體 Polyclonal Antibody to Glycoprotein V, Platelet (GP5)
kl089Mu01 谷胱甘肽S轉(zhuǎn)移酶κ1(GSTκ1)多克隆抗體 Polyclonal Antibody to Glutathione S Transferase Kappa 1 (GSTk1)
kl241Mu01 Kruppel樣因子4(KLF4)多克隆抗體 Polyclonal Antibody to Kruppel Like Factor 4, Gut (KLF4)
kl135Mu01 絲裂原激活蛋白激酶激酶激酶激酶5(MAP4K5)多克隆抗體 Polyclonal Antibody to Mitogen Activated Protein Kinase Kinase Kinase Kinase 5 (MAP4K5)
kl068Mu01 多藥耐藥關(guān)聯(lián)蛋白1(MRP1)多克隆抗體 Polyclonal Antibody to Multidrug Resistance Associated Protein 1 (MRP1)
